Medical Materials Operating Department

This content is intended for healthcare professionals.

This content is intended for healthcare professionals.

Bonarc®

Bone regeneration approaches nature.*

*"Bone regeneration approaches nature" is quoted from the fact that a generated bone after 6 months following Bonarc implantation has a structure similar to that of the existing bone.
Reference: Tanuma Y, et al, Oral Surg Oral Med Oral Pathol Oral Radiol Endod 115: 9-17, 2013

  • Dental implant placement

    Dental implant placement

    We have received a regulatory approval for the application of bone regeneration prior to dental implant placement from the Ministry of Health, Labour and Welfare of Japan.

  • Alveolar cleft

    Alveolar cleft

    We would like to help children avoid the discomfort associated with autologous bone grafting.

  • For bone defect by cystectomy

    Cyst

    For bone defect by cystectomy

The bone substitute can contribute to the enhanced handling during surgery, and its new constituent materials work on remodeling.

「Bonarc」disc(10)/rod(1) 「Bonarc」disc(10)/rod(1)

Bone void filler with collagen

  • Discs
  • Rods

Japanese Medical Device Approval No 30100BZX00025000
*Bonarc is approved for manufacturing and sales only in Japan, but not in foreign countries.

It is a composite material of octacalcium phosphate (OCP; Ca8H2(PO4)6・5H2O) and collagen developed through industry–academia joint research.

An artificial bone used for the “application of dental implants,” for more natural bone regeneration

  • Application for dental implants

  • Natural bone
    regeneration

  • Spill-resistant
    solid shape

  • Biocompatible collagen

  • Japan-made bone
    substitute
    material

Manufacturer

Manufacturer
1-13-1, Umeda, Kita-ku, Osaka 530-0001, Japan
https://www.toyobo-global.com/

* The Bonarc is a registered trademark of TOYOBO CO., LTD., Japan which indicates its Bone void filler with collagen.